Moderna expects to know if COVID-19 vaccine is safe by Nov.; NY files opioid lawsuit against J&J; #WhoSavesTheirLives: An initiative advocating better support for HCPs.
Plus people moves at AbelsonTaylor and Experity.
U.S. plans to distribute vaccine within 24 hours of approval; CDC needs $6B to distribute a potential vaccine nationwide; Eli Lilly’s antibody helped reduce hospitalization for coronavirus patients.
This week’s Haymarket Media Coronavirus Briefing is 1,325 words and will take you seven minutes to read.
Doximity polled patients and doctors to determine the state of telemedicine after a spike in use due to the COVID-19 pandemic.
Court upholds New York law requiring drugmakers to fund opioid programs; More Black and Hispanic children are dying from coronavirus; Eli Lilly’s rheumatoid arthritis drug helps speed recovery in COVID-19 patients.
The effort is part of the agency’s broader “Operation Respect” push.
Study suggests genes play a role in COVID-19; U.S. AstraZeneca vaccine trial remains on hold; Gilead acquired cancer drugmaker Immunomedics for $21B.
The two agencies will share expertise in their regulatory markets.
NIH begins studies of blood thinners to treat COVID-19; Global vaccine trust may be a challenge for COVID-19 vaccination; Register to attend MM+M’s upcoming webcast on maximizing marketing efforts.